Raleigh Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-250
| Closed | -$258 | – | 673 |
|
|
2024
Q4 | $258 | Hold |
250
| – | – | ﹤0.01% | 976 |
|
|
2024
Q3 | $295 | Hold |
250
| – | – | ﹤0.01% | 950 |
|
|
2024
Q2 | $305 | Hold |
250
| – | – | ﹤0.01% | 937 |
|
|
2024
Q1 | $545 | Hold |
250
| – | – | ﹤0.01% | 878 |
|
|
2023
Q4 | $388 | Hold |
250
| – | – | ﹤0.01% | 1005 |
|
|
2023
Q3 | $323 | Hold |
250
| – | – | ﹤0.01% | 908 |
|
|
2023
Q2 | $430 | Hold |
250
| – | – | ﹤0.01% | 793 |
|
|
2023
Q1 | $378 | Hold |
250
| – | – | ﹤0.01% | 813 |
|
|
2022
Q4 | $400 | Hold |
250
| – | – | ﹤0.01% | 738 |
|
|
2022
Q3 | $0 | Hold |
250
| – | – | ﹤0.01% | 799 |
|
|
2022
Q2 | $0 | Hold |
250
| – | – | ﹤0.01% | 611 |
|
|
2022
Q1 | $1K | Buy |
+250
| New | +$1K | ﹤0.01% | 557 |
|